The potential of anionic liposomes for oligonucleotide delivery was explored because the requirement for a net-positive charge on transfection-competent cationic liposome-DNA complexes is ambiguous. Liposomes composed of phosphatidylglycerol and phosphatidylcholine were monodisperse and encapsulated oligonucleotides with 40 -60% efficiency. Ionic strength, bilayer charge density, and oligonucleotide chemistry influenced encapsulation. To demonstrate the biological efficacy of this vector, antisense oligonucleotides to p53 delivered in anionic liposomes were tested in an in vitro model of excitotoxicity. Exposure of hippocampal neurons to glutamate increased p53 protein expression 4-fold and decreased neuronal survival to ϳ35%. Treatment with 1 M p53 antisense oligonucleotides in anionic liposomes prevented glutamate-induced up-regulation of p53 and increased neuronal survival to ϳ75%. Selective inhibition of gene expression with antisense oligonucleotides (AsONs) 1 is both a popular technique for probing fundamental questions of neuroscience (1) and a potential therapeutic strategy for the treatment of neurodegenerative diseases (2). However, the elegance of the antisense concept belies the considerable challenge of their intracellular delivery (3). Chemical modifications of ONs that enhance nuclease-resistance (e.g. phosphorothioates) have poor cellular uptake (ϳ5-10%) and cause non-sequence-specific effects, raising questions about the efficacy and selectivity of antisense drugs (4). Cationic lipids and polycationic polymers used as ON delivery vectors have met with limited success due to a number of variables that seem to affect vector performance (3, 5). Mechanistic aspects of cationic lipid-mediated delivery are poorly understood because of the physical heterogeneity of cationic lipid-ON complexes (6) that may contribute to their toxicity toward several cell types (7). Application of antisense technology to the nervous system presents an even greater challenge because of the post-mitotic nature of neurons and their exquisite sensitivity to their microenvironment. Cationic lipids and polymers have been used to deliver nucleic acids to neurons, generally at efficiencies of 0.5-5% (8). Factors that influence transgene expression or target protein inhibition include neuronal maturity at the time of transfection, the type of cationic lipid used (8), and the net charge of the lipid-DNA complex (9). Cationic lipids per se have also been reported to be toxic to neurons (8, 10).Glutamate, the main excitatory neurotransmitter in the brain, plays a central role in the pathogenesis of stroke, epilepsy, and neurodegenerative diseases such as Alzheimer's disease. Excitotoxicity results in increased translation (11) and stabilization (12) of the p53 protein, which in turn alters the levels of redox proteins (13), resulting in neuronal loss. p53 has also been shown to accumulate in mitochondria, leading to mitochondrial dysfunction and activation of the caspase cascade (14). As further proof of the involvement of p53 in ne...